ARCHIVES

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 25 | June 20, 1986

Download PDF Visit The Full Archive

Related Articles

Abbott Offers New Education Awards

June 12, 1987

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Preyer Supported For Chairmanship

January 26, 1979

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992